1 / 32

Anesthesia for Non-Obstetric Surgery in Pregnancy

Anesthesia for Non-Obstetric Surgery in Pregnancy. Joe Dietrick, CRNA, M.A. Have A Nice Day Anesthesia, LLC Chillicothe, MO. Objectives. Identify the most common procedures Identify factors of: maternal safety, fetal teratogenicity, intrauterine asphyxia, & preterm labor

galena-hull
Download Presentation

Anesthesia for Non-Obstetric Surgery in Pregnancy

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Anesthesia forNon-Obstetric Surgery in Pregnancy Joe Dietrick, CRNA, M.A. Have A Nice Day Anesthesia, LLC Chillicothe, MO

  2. Objectives • Identify the most common procedures • Identify factors of: maternal safety, fetal teratogenicity, intrauterine asphyxia, & preterm labor • Intraoperative FHR monitoring • Laparoscopic surgery • Anesthetic management

  3. Introduction(1 of 3) • Surgeon’s approach to surgery in pregnancy: • 1990: If medical or surgical treatment plan usually followed for a nonpregnant woman is altered because of pregnancy, there must be strong justification for its modification. • Occurrence: Approx 50K/yr (1-2%)

  4. Introduction(2 of 3) • Most common procedures5: • Appendectomy • Cholecystectomy • Ovarian disorders • Trauma • Breast / cervical dz • Bowel obstruction

  5. Introduction(3 of 3) • 4 Areas of Unique Concern: • Maternal safety • Fetal teratogenicity • Intrauterine fetal asphyxia • Preterm labor • Appropriate anesthetic care will require understanding of the current knowledge of these areas.

  6. Maternal SafetySignificant changes after 1st trimester • Uterine enlargement • AO/VC compression: LUD > 20 wks • Respiratory • Increased VO2 + decreased reserve risks HYPOxia • Chronic resp alkalosis (PaCO2 ≈ 32) • Potential AW difficulty • CNS • Up to 40% decrease in MAC • Increased LA sensitivity • GI • Increased aspiration risk from physical and biochemical changes > 18-20 wks

  7. Teratogenicity: general • Fetal risk: • 0-15d  usually embryotoxic (EGA 2-4 wks) • 15-60d (organogenesis)  great risk to fetus. • 31-71d EGA (4-10 wks) • Then functional deficits • Nearly all drugs have been demonstrated to be teratogenic in some species at some dose.

  8. Teratogenicity: Research Issues • Difficulty in applying animal & human studies to practice: • Variations in susceptibility between species • Human studies are retrospective • Difficulty in controls • Confounding multiple variables • Small numbers inadequate for statistical significance

  9. Teratogenicity: BZD, Opioids • BZD/minor tranquilizers: • Associated with increased anomalies • BZD • Initally associated with increased cleft palates • Later studies: no relationship • FDA (1975): minor tranquilizers should almost always be avoided in 1st trimester • Single dose: no effect • Synthetic opioids: animal studies not teratogenic

  10. Teratogenicity: MR, LA • Muscle relaxants: • minimal placental transfer • Local Anesthetics: • Lidocaine used in PG rats w/o complication • No evidence of problems in humans • Cocaine is a known teratogen • IUGR, preterm delivery, and increased risk of abruptio placentae

  11. Teratogenicity: Induction Agents • Induction Agents: • Ketamine – not teratogenic • >1 mg/kg  ↑risk of preterm labor • Thiopental – not teratogenic in conventional doses • Propofol in pregnant ewe1 • No adverse fetal effects compared to thiopental • Propofol + Succinylcholine demonstrated cases of severe maternal bradycardia in ewe

  12. Teratogenicity: N2O • N2O: • Theoretical risk is decreased but reversible DNA synthesis • Pretreatment with folinic acid is not proven effective in preventing neurogenic teratogenicity in animals • Conclusion • Teratogenic only under extreme conditions; however, slightly increased abortion risk?

  13. Teratogenicity: Inhalation Agents • Volatile anesthetics: • Shown teratogenic in some species • VA + N2O in PG rats showed no anomalies at any gestational age • Like N2O, slightly increased risk of abortion?

  14. Teratogenicity: non-drug factors • Anesthesia &/or surgery may cause • HYPOxia • HYPOtension • HYPERcapnia • ↑ temp • ↑ / ↓ BS • Effects may be teratogenic With a critical event, pose greatest fetal risk

  15. Intrauterine Fetal Asphyxia(1 of 4) • Avoided by maintaining the following variables of fetal respiration • Maternal oxygenation • Maternal carbon dioxide tension • Uterine blood flow

  16. Intrauterine Fetal Asphyxia(2 of 4) • Maternal oxygenation • HYPOxia can occur with either regional or general anesthesia • HYPERoxia does not promote either fetal HYPOxia from UA constriction, or retrolental fibroplasia • Fetal pO2 <=60 due to maternal/placental mismatch and high placental VO2

  17. Intrauterine Fetal Asphyxia(3 of 4) • Maternal CO2 • Fetal CO2 related to maternal level • HYPOcapnia • Increased ventilation may reduce venous return or provoke UA vasoconstriction, and cause a fall in UBF • Alkalosis reduces release of O2 from maternal hemoglobin • Target EtCO2≈ 32-34 mmHg

  18. Intrauterine Fetal Asphyxia(4 of 4) • Uterine blood flow • HYPOtension may be caused by • anesthetics (GA or RA) • AO/VC compression • Vasoconstriction may be caused by endogenous or exogenous sympathetic activity, including injection of ketamine (> 2mg/kg) • Neostigmine (anti-Ach-ase) • Glyco, then slow admin with FHR monitoring

  19. Preterm Labor(1 of 2) • Anesthetic effect on preterm labor unknown • Surgical procedures in abdomen and especially near uterus are associated with preterm labor • >24 wks: 22% delivered 1st week post-op appendectomy (1991, N=778)

  20. Preterm Labor(2 of 2) • Pre-emptive pro-gestational drugs • Have not been demonstrated effective at preventing preterm labor or abortion • Ketamine, vasopressors, & anticholinesterases • increase uterine tone and therefore increase risk. • Volatile agents • decrease uterine tone & may have benefit

  21. Intraoperative FHR monitoring • Horrigan, et al (1999)2 reviewed 12 articles • Conclusion: 20 years experience  no documented evidence that FHR monitoring intraoperatively is required. • Letter in response, by Kendrick & Neiger • 18 cases, 10 non-cardiac • Uterine activity requiring tocolysis 3/10 • One episode of bradycardia assoc. with EBL • Must individualize decision

  22. ACOG Opinion # 474 (02/2011)3 • “The decision to use fetal monitoring should be individualized and, if used, should be based on gestational age, type of surgery, and facilities available. Ultimately, each case warrants a team approach (anesthesia and obstetric care providers, surgeons, pediatricians, and nurses) for optimal safety of the woman and the fetus.”

  23. More detail…3 • If FHR used: • + Neonatal/ped serv • CS capability available • Qualified individual for FHR interpretation • When • Previable: FHR before & after • Viable: FHR & Toco before & after (minimum)

  24. Intraoperative FHR?3 • The fetus is viable. • It is physically possible to perform intraoperative electronic fetal monitoring. • A health care provider with obstetric surgery privileges is available and willing to intervene during the surgical procedure for fetal indications. • When possible, the woman has given informed consent to emergency cesarean delivery. • The nature of the planned surgery will allow the safe interruption or alteration of the procedure to provide access to perform emergency delivery.

  25. Laparoscopic Surgery4 • No difference in indications • Timing • Elective – avoid • Optimal – Early 2nd trimester • Performed as late as 34 wks EGA • Initial trocar approach • No difference between open & blind • Midline: ≥ 6 cm above fundus

  26. Laparoscopic Surgery4 • Adverse effects of CO2 insufflation: • Maternal  fetal acidosis • Pneumoperitoneum 8 – 12 mmHg (< 15) • Avoid: N2O (or < 50%), extreme position • EtCO2 32 -34 mmHg • Hyperventilation deleterious

  27. MAC Issues5 • Risk of hypoventilation  fetal acidosis • Difficulty in evaluating resp status • Potential difficulty with emergent AW •  risk of aspiration • Compounded by co-existing morbidities

  28. Plan5 • Timing • Avoid if possible • Risk vs benefit; OB consult • Non-emergent: early/mid 2nd trimester • Perioperative monitoring • Con’t FHR & uterine activity if possible. • FHR >18 wks6 or > 23 wks • Ability to perform emergent CS • Plan action for persistent fetal ↓ HR

  29. Plan5 • Anesthesia • Both GA & RA used • Maintaning variables of fetal well-being most important • Regional generally preferred • > 16 wks • Aspiration prophylaxis • Resolve dehydration / hypovolemia • LUD • Maintain variables of fetal well-being

  30. Plan5 • Pneumatic compression devices perioperatively • Postoperative management • Opiates & antiemetics as needed • Avoid NSAIDs, esp >32 weeks • Emergent delivery • Effects of anesthetics may require neonatal support • Muscle relaxants do NOT cross placenta

  31. FDA Pregnancy Categories

  32. References Unless otherwise noted all information is from the OB text: • Naughton, N & Cohen, S. (2004). Non-obstetric Surgery in Pregnancy. In Chestnut, D. (Ed), Obstetric Anesthesia, Principles & Practice, 3rd Ed ( Pg 255-272) Other references • Alon, et al. Effects of propofol and thiopental on maternal and fetal cardiovascular and acid-base variables in the pregnant ewe. Anesthesiology. 1993 Mar;78(3):562-76 • Horrigan TJ, Villarreal R, Weinstein L. Are obstetrical personnel required for intraoperative fetal monitoring during nonobstetric surgery? J Perinatol. 1999 Mar;19(2):124-6. • ACOG Committee Opinion Number 284: Non-obstetric surgery in pregnancy. Obstet Gynecol. 2011;117:420-21. • Stany, M, et al. Laparoscopic surgery in pregnancy. Retrieved 04/01/2011) from UpToDate. Website: http://www.uptodate.com/contents/laparoscopic-surgery-in-pregnancy?source=search_result&selectedTitle=1%7E150 • Norwitz, E., & Joong, S. Management of pregnant women undergoing non-obstetric surgery. Retrieved 04/01/2011) from UpToDate. Website: http://uptodateonline.com/online/content/topic.do?topicKey=pregcomp/21735&selectedTitle=1~150 • Ni Mhuircheartaigh RN, O’Gorman DA. Anesthesia in the pregnant patient for non-obstetric surgery. J Clin Anesth 2006;18:60- 6.

More Related